We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Events

09 Apr 2024 - 12 Apr 2024
15 Apr 2024 - 17 Apr 2024
23 Apr 2024 - 26 Apr 2024

Biomarker Identified for Basal-Like Breast Cancer

By LabMedica International staff writers
Posted on 11 Aug 2015
Print article
Image: The Zeiss Axiovert 200M inverted microscope (Photo courtesy of Michigan Technological University).
Image: The Zeiss Axiovert 200M inverted microscope (Photo courtesy of Michigan Technological University).
Basal-like breast cancer (BLBC) is an aggressive form of breast cancer and is often referred to as triple negative, which means it is not responsive to the common medical therapeutics, and is more likely to metastasize.

Interleukins (IL) comprise a superfamily of pleiotropically acting cytokines that are present in the tumor microenvironment and are implicated in a wide variety of immunomodulatory functions, including cell maturation, proliferation, migration, and adhesion.

Scientists at the Boston University Medical Center (Boston, MA, USA) working in conjunction with those at the University of Cyprus (Nicosia, Cyprus) compared the markers on the surface of the cancer cells to gene expression profile of breast tumors deposited by scientists in international public databases. An unbiased approach using gene expression profiling of a BLBC progression model and in silico leveraging of pre-existing tumor transcriptomes were used to uncover metastasis-promoting genes.

The investigators used various techniques including breast cell cultures; gene expression microarray analysis was followed by in vitro validation and cell migration assays to elucidate the downstream molecular pathways involved in this process. Chemotaxis migration assays were performed and counted by using an Axiovert 200M inverted microscope (Carl Zeiss; Oberkochen, Germany). Real-time polymerase chain reaction (PCR), Western blots and immunological assays were also performed.

The scientists found that a molecule named Interleukin-13 receptor subunit alpha-2 (IL13Rα2) was abundant in metastatic or late-stage BLBC. When they looked at publically available data on patients, they were able to predict the likelihood of progression-free survival based on whether the cancer cells had high levels of IL13Rα2. The group also discovered that a subtype of BLBC that tended to spread to the lungs quickly had high IL13Rα2 levels. High levels of Signal transducer and activator of transcription 6 (STAT6) and Tumor protein p63 (TP63) expression were associated with longer distant metastasis-free survival of patients with breast cancer.

Sam Thiagalingam, PhD, associate professor of genetics and genomics, and coauthor of the study, said, “This discovery offers a glimmer of hope for patients stricken with BLBC. Personalized cancer therapies could be developed by targeting breast cancer cells that express copious levels of IL13Rα2.” The study was published on July 27, 2015, in the journal Breast Cancer Research.

Related Links:

Boston University Medical Center 
University of Cyprus 
Carl Zeiss 


Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Specimen Collection & Transport
Complement 3 (C3) Test
GPP-100 C3 Kit
Gold Member
Real-time PCR System
GentierX3 Series

Print article

Channels

Clinical Chemistry

view channel
Image: Reaching speeds up to 6,000 RPM, this centrifuge forms the basis for a new type of inexpensive, POC biomedical test (Photo courtesy of Duke University)

POC Biomedical Test Spins Water Droplet Using Sound Waves for Cancer Detection

Exosomes, tiny cellular bioparticles carrying a specific set of proteins, lipids, and genetic materials, play a crucial role in cell communication and hold promise for non-invasive diagnostics.... Read more

Molecular Diagnostics

view channel
Image: MOF materials efficiently enrich cfDNA and cfRNA in blood through simple operational process (Photo courtesy of Science China Press)

Blood Circulating Nucleic Acid Enrichment Technique Enables Non-Invasive Liver Cancer Diagnosis

The ability to diagnose diseases early can significantly enhance the effectiveness of clinical treatments and improve survival rates. One promising approach for non-invasive early diagnosis is the use... Read more

Hematology

view channel
Image: The low-cost portable device rapidly identifies chemotherapy patients at risk of sepsis (Photo courtesy of 52North Health)

POC Finger-Prick Blood Test Determines Risk of Neutropenic Sepsis in Patients Undergoing Chemotherapy

Neutropenia, a decrease in neutrophils (a type of white blood cell crucial for fighting infections), is a frequent side effect of certain cancer treatments. This condition elevates the risk of infections,... Read more

Pathology

view channel
Image: The OvaCis Rapid Test discriminates benign from malignant epithelial ovarian cysts (Photo courtesy of INEX)

Intra-Operative POC Device Distinguishes Between Benign and Malignant Ovarian Cysts within 15 Minutes

Ovarian cysts represent a significant health issue for women globally, with up to 10% experiencing this condition at some point in their lives. These cysts form when fluid collects within a thin membrane... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.